Current SpayVac Projects

Validation Batch

We manufactured our validation batch the last week of June 2018.  We manufactured a second batch of product in March 2019  and  have  now  completed  three  batches. We are planning a production run of three more batches. This work will give us five validation batches, which are needed for EPA filing.  

EPA Filing

We are currently in the process of putting together our EPA filing. We expect to file by Q4 2019  or  early  2020.    Approval  could  take  up  to  10  months. 

Field Trials - Wildhorses

We are interested in the following areas with our SpayVac pZP vaccine:

  • Conducting trials to optimize antibody  responses
  • An injection site comparison trial

Urban Deer Trial

Although four studies demonstrate single-dose efficacy in both white-tail and fallow deer species, we would be interested in partnering with a group to optimize administration practices in deer.  Please contact us if you are interested.

Other Projects

Our goal is to develop a portfolio of vaccines. The priority populations for which we intend to expand our portfolio are:

  • Feral cats
  • Street dogs / stray dog populations
  • Kangaroos
  • Camels
  • Wild hogs
  • Macaques-- one trial is currently  on  going.
  • Dingos
  • Burros
  • Rodents

These populations represent over 1,000,000,000 animals in overabundance.  In some of these species  we may be able to use SpayVac pZP our lead product.  In other species we will formulate a different vaccine with a different antigen (active ingredient).